Default: Revue Neurologique

ISSN: 0035-3787

Journal Home

Journal Guideline

Revue Neurologique Q2 Unclaimed

Elsevier Masson s.r.l. France
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Revue Neurologique is a journal indexed in SJR in Neurology (clinical) and Neurology with an H index of 59. It has an SJR impact factor of 0,786 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,786.

Revue Neurologique focuses its scope in these topics and keywords: multiple, patients, sclerosis, case, spg, year, withdrawn, treatments, study, rare, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Revue Neurologique

0,786

SJR Impact factor

59

H Index

179

Total Docs (Last Year)

531

Total Docs (3 years)

8810

Total Refs

1001

Total Cites (3 years)

342

Citable Docs (3 years)

1.77

Cites/Doc (2 years)

49.22

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


multiple, patients, sclerosis, case, spg, year, withdrawn, treatments, study, rare, cerveau, complex, disease, muscles, quality, life, sclerosisle, sclerosiscan, discontinue, diseasemodifying, génétiqueneurosarcoïdose, longitudinal, mofétila, mutation, mycophénolate, nopredictors, relapsingremitting,



Best articles by citations

Pieges diagnostiques du syndrome du canal carpien

View more

Vitamine D et sclerose en plaques. etude prospective d'une cohorte de patients de la region Poitou-Charentes

View more

Bases neurologiques de l'affect douloureux

View more

Histomolecular classification of adult diffuse gliomas: The diagnostic value of immunohistochemical markers

View more

New concepts in paraneoplastic neurological syndromes

View more

Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Yes

View more

Interêt du cyclophosphamide dans les formes progressives de SEP

View more

Interêt et limites de l'examen polymyographique dans l'etude des dystonies

View more

Actualite sur l'immunotherapie de la maladie d'Alzheimer

View more

Paralysie du plexus brachial au reveil

View more

L'IRM est-elle utile dans le suivi des patients atteints de sclerose en plaques ? Oui

View more

Paralysie periodique thyreotoxique hypokaliemique revelatrice d'une maladie de Basedow chez un caucasien

View more
SHOW MORE ARTICLES

Suivi a 5 ans de la stimulation bilaterale du noyau subthalamique dans la maladie de Parkinson

View more

La neuro-ophtalmologie française en 2010

View more

Hemiballisme vasculaire par atteinte extraluysienne

View more

Strategies anti-angiogeniques dans le glioblastome

View more

Nouveautes dans le diagnostic et le traitement des neuropathies peripheriques liees a l'amylose AL et au syndrome POEMS

View more

Toxine botulique et douleur des neuropathies peripheriques : que peut-on en attendre ?

View more

Une cause meconnue de myelopathie par carence en cuivre : l'utilisation de pate adhesive dentaire

View more

Glycemie, volume de l'infarctus et pronostic de la thrombolyse

View more

A painless complete abdominal wall palsy with groin and thigh paresthesiae related to traffic accident injury

View more

Chimiotherapie neoadjuvante dans les astrocytomes fibrillaires de grade II symptomatiques non operables de l'adulte

View more

Efficacy of microvascular decompression on the vascular compression type of neurogenic hypertension: A meta-analysis

View more

Avant-propos

View more

FAQS